Wire · operational-macro
BD partners with US government to expand domestic manufacturing
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 October 2026 · Fusion42 review
BD has partnered with the US government to invest $19 billion over several years to expand US manufacturing of essential medical consumables, aiming to increase domestic production share to 80% and ensure supply chain resilience. This includes tariff relief under Section 232, supporting long-term manufacturing certainty.
This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 6 Oct 2026 and 8 Oct 2026.
◆ ◆ The Wire takeaway
US manufacturing for medical consumables is headed for a major boost as BD's huge investment and government backing open the door for you to supply the growing domestic market. This deal changes the game for companies reliant on imports by creating new chances to win business closer to home.
◆ Coverage
4 sources · first reported 6 Oct 2026 · latest 8 Oct 2026
◆ Related on Wire
◆ Topics